Glycomic Analysis of Prostate Cancer 5f. Work Unit Number 7. Performing Organization Name(s) and Address(es) 8. Performing Organization Report Number Approved for Public Release; Distribution Unlimited Prostate Cancer, Glycomic Analysis, Health Disparity 16. Security Classification Of: 17. Limitatio
暂无分享,去创建一个
[1] Haojie Lu,et al. N-linked glycan changes of serum haptoglobin β chain in liver disease patients. , 2011, Molecular bioSystems.
[2] C. Lebrilla,et al. Annotation and structural analysis of sialylated human milk oligosaccharides. , 2011, Journal of proteome research.
[3] A. Varki,et al. Biomedical differences between human and nonhuman hominids: potential roles for uniquely human aspects of sialic acid biology. , 2011, Annual review of pathology.
[4] Pauline M Rudd,et al. Ultra performance liquid chromatographic profiling of serum N-glycans for fast and efficient identification of cancer associated alterations in glycosylation. , 2010, Analytical chemistry.
[5] Pauline M Rudd,et al. A systematic approach to protein glycosylation analysis: a path through the maze. , 2010, Nature chemical biology.
[6] V. Reinhold,et al. The N-glycome of human plasma. , 2010, Journal of proteome research.
[7] Mary Ann Comunale,et al. Linkage Specific Fucosylation of Alpha-1-Antitrypsin in Liver Cirrhosis and Cancer Patients: Implications for a Biomarker of Hepatocellular Carcinoma , 2010, PloS one.
[8] J. Doré,et al. The clinical Pseudomonas fluorescens MFN1032 strain exerts a cytotoxic effect on epithelial intestinal cells and induces Interleukin-8 via the AP-1 signaling pathway , 2010, BMC Microbiology.
[9] Paul C Guest,et al. Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia. , 2010, Journal of proteome research.
[10] L. Kiessling,et al. Chemical approaches to glycobiology. , 2010, Annual review of biochemistry.
[11] J. Michalski,et al. Immunoglobulins are the major glycoproteins involved in the modifications of total serum N‐glycome in cirrhotic patients , 2010, Proteomics. Clinical applications.
[12] T. Rejtar,et al. Improved sample preparation method for glycan analysis of glycoproteins by CE‐LIF and CE‐MS , 2010, Electrophoresis.
[13] J. Michalski,et al. Modifications of human total serum N‐glycome during liver fibrosis–cirrhosis, is it all about immunoglobulins? , 2010, Proteomics. Clinical applications.
[14] P. Rudd,et al. Separation of 2-aminobenzamide labeled glycans using hydrophilic interaction chromatography columns packed with 1.7 microm sorbent. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[15] I. Rudan,et al. Variability, heritability and environmental determinants of human plasma N-glycome. , 2009, Journal of proteome research.
[16] H. Perreault,et al. Mass spectrometric study of N-glycans from serum of woodchucks with liver cancer. , 2009, Rapid communications in mass spectrometry : RCM.
[17] Richard D. Cummings,et al. The repertoire of glycan determinants in the human glycome. , 2009, Molecular bioSystems.
[18] Joris Delanghe,et al. GlycoFibroTest Is a Highly Performant Liver Fibrosis Biomarker Derived from DNA Sequencer-based Serum Protein Glycomics*S , 2009, Molecular & Cellular Proteomics.
[19] Y. Mechref,et al. Detection of Hepatocellular Carcinoma Using Glycomic Analysis , 2009, Clinical Cancer Research.
[20] C. Van Steenkiste,et al. Alteration of protein glycosylation in liver diseases. , 2009, Journal of hepatology.
[21] Chao Yang,et al. Comparison of public peak detection algorithms for MALDI mass spectrometry data analysis , 2009, BMC Bioinformatics.
[22] Yehia Mechref,et al. High-throughput solid-phase permethylation of glycans prior to mass spectrometry. , 2008, Rapid communications in mass spectrometry : RCM.
[23] Yehia Mechref,et al. Analysis of MALDI-TOF mass spectrometry data for discovery of peptide and glycan biomarkers of hepatocellular carcinoma. , 2008, Journal of proteome research.
[24] Mary Ann Comunale,et al. Increased Levels of Galactose-Deficient Anti-Gal Immunoglobulin G in the Sera of Hepatitis C Virus-Infected Individuals with Fibrosis and Cirrhosis , 2007, Journal of Virology.
[25] K. Håkansson,et al. Electron capture dissociation of oligosaccharides ionized with alkali, alkaline Earth, and transition metals. , 2007, Analytical chemistry.
[26] Y. Mechref,et al. Miniaturized separation techniques in glycomic investigations. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[27] Roger Williams. Global challenges in liver disease , 2006, Hepatology.
[28] Alexandre Louvet,et al. Mass spectrometric approach for screening modifications of total serum N-glycome in human diseases: application to cirrhosis. , 2006, Glycobiology.
[29] R. Dwek,et al. Interaction of mannan binding lectin with alpha2 macroglobulin via exposed oligomannose glycans: a conserved feature of the thiol ester protein family? , 2006, The Journal of biological chemistry.
[30] Yehia Mechref,et al. Solid-phase permethylation of glycans for mass spectrometric analysis. , 2005, Rapid communications in mass spectrometry : RCM.
[31] Jeffrey S. Morris,et al. Improved peak detection and quantification of mass spectrometry data acquired from surface‐enhanced laser desorption and ionization by denoising spectra with the undecimated discrete wavelet transform , 2005, Proteomics.
[32] D. Ashline,et al. Congruent strategies for carbohydrate sequencing. 1. Mining structural details by MSn. , 2005, Analytical chemistry.
[33] C. Bertozzi,et al. Glycans in cancer and inflammation — potential for therapeutics and diagnostics , 2005, Nature Reviews Drug Discovery.
[34] D. Harvey. Structural determination of N‐linked glycans by matrix‐assisted laser desorption/ionization and electrospray ionization mass spectrometry , 2005, Proteomics.
[35] James Paulson,et al. Automatic annotation of matrix‐assisted laser desorption/ionization N‐glycan spectra , 2005, Proteomics.
[36] L. Klassen,et al. Immunologic mechanisms of alcoholic liver injury. , 2004, Seminars in liver disease.
[37] S. Lindgren,et al. Diagnostic accuracy of alpha(1)-acid glycoprotein fucosylation for liver cirrhosis in patients undergoing hepatic biopsy. , 2002, Clinical chemistry.
[38] R. Dwek,et al. Glycosylation and the complement system. , 2002, Chemical reviews.
[39] H. Adami,et al. The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis , 2001, Hepatology.
[40] Pauline M Rudd,et al. Determining the Structure of Oligosaccharides N‐ and O‐Linked to Glycoproteins , 2000, Current protocols in protein science.
[41] K. Yasukawa,et al. Discrimination of liver cirrhosis from chronic hepatitis by measuring the ratio of Aleuria aurantia lectin-reactive serum cholinesterase to immunoreactive protein. , 1999, Clinica chimica acta; international journal of clinical chemistry.
[42] D. Hochstrasser,et al. New alterations of serum glycoproteins in alcoholic and cirrhotic patients revealed by high resolution two-dimensional gel electrophoresis. , 1996, Biochemical and biophysical research communications.
[43] C. Record,et al. Monosaccharide composition of haptoglobin in liver diseases and alcohol abuse: large changes in glycosylation associated with alcoholic liver disease. , 1994, Clinica chimica acta; international journal of clinical chemistry.
[44] G. Turner. N-glycosylation of serum proteins in disease and its investigation using lectins. , 1992, Clinica chimica acta; international journal of clinical chemistry.
[45] S. Thompson,et al. Changes in fucose metabolism associated with heavy drinking and smoking: a preliminary report. , 1991, Clinica chimica acta; international journal of clinical chemistry.
[46] C. Barsigian,et al. Carbohydrate abnormalities of N-linked plasma glycoproteins in liver disease. , 1987, Laboratory investigation; a journal of technical methods and pathology.
[47] N. Kochibe,et al. Systematic fractionation of oligosaccharides of human immunoglobulin G by serial affinity chromatography on immobilized lectin columns. , 1987, Analytical biochemistry.
[48] F. I. Lee. Immunoglobulins in viral hepatitis and active alcoholic liver-disease. , 1965, Lancet.
[49] Y. Mechref,et al. Identification of N-glycan serum markers associated with hepatocellular carcinoma from mass spectrometry data. , 2010, Journal of proteome research.
[50] Haixu Tang,et al. Automated interpretation of MS/MS spectra of oligosaccharides , 2005, ISMB.
[51] W. Becker. Variations of immunoglobulins in disease. , 1975, Journal of clinical pathology. Supplement.